Peripheral neuropathy presents clinically in 30–60% of people living with human immunodeficiency virus (HIV), and nearly all AIDS patients have an evidence of peripheral neuropathy at autopsy. HIV-associated sensory neuropathy (HIV-SN) is one of the most common forms of peripheral neuropathy. It has been found that 57% of HIV-infected individuals have distal symmetrical SN and …
Pfizer announced that it has stopped a Phase 3 clinical trail of Lyrica for patients with HIV neuropathy based on an interim analysis of the results. “The results of this study show the complexities of studying pain, particularly in a difficult-to-treat condition such as neuropathic pain associated with HIV neuropathy for which there are no …
At the 6th World Congress of the World Institute of Pain in Miami Beach this month, Dr. Kenneth Candido presented a poster on the success of implanting a permanent device that delivers constant spinal cord stimulation to offer pain relief to patients with HIV-related polyneuropathy. Dr. Candido is chair and professor in the Department of …
Spinal Cord Stimulation Effective for HIV Neuropathy Read More »
Biopharmaceutical company, NeurogesX, announced it submitted a supplemental new drug to the US FDA seeking to expand the label to include an application for the management of pain due to HIV-associated neuropathy. FDA Priority Review status is given to drug candidates that offer major advances in treatment and accelerated the standard review time. HIV-PN is …
In a study conducted by Dr. Sugato Banerjee of the HIV Neurobehavioral Research Center in San Diego and his colleagues a potential connection has been found between elevated lipid levels and neuropathy in people receiving antiretroviral treatments. Managing the elevated triglyceride levels may reduce the risk of developing this debilitating nerve condition. Â READ MORE Source: …
High Triglycerides Increase Risk of Neuropathy for Patients with HIV Read More »
In a report presented at the American Academy of Pain Medicine, Dr. Stephen J. Brown, states that difficult to treat HIV-associated neuropathic pain appears to be eased for at least three months with a one-time, 30-minute application of an 8% capsaicin patch. Brown said, “More than half of people with HIV-infection develop neuropathy, and about …
Pregabalin for Painful HIV Neuropathy June 2010:Â Dr. David Simpson and a team of researchers have been evaluating effective treatments for painful HIV neuropathy. Their current findings, ‘A randomized, double-blind, placebo-controlled trial’ have been published in the Neurology journal. Learn more about Pregabalin for Painful HIV Neuropathy Source: Dr. Simpson, Mount Sinai Learn more about Dr. …
